Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010-2018.

ABSTRACT:

Importance

Improving access to naloxone is a critical component of the nation's strategy to curb fatal overdoses in the opioid crisis. Standing or protocol orders, prescriptive authority laws, and immunity provisions have been passed by states to expand access, but less attention has been given to potential financial barriers to naloxone access.

Objective

To assess trends in out-of-pocket (OOP) costs for naloxone and examine variation in OOP costs by drug brand and payer.

Design, setting, and participants

This observational study analyzed US naloxone claims data from Symphony Health and associated OOP costs for individuals filling naloxone prescriptions by drug brand and payer between January 1, 2010, to December 31, 2018. The data were analyzed from March 31, 2021, t

SUBMITTER: Peet ED 

PROVIDER: S-EPMC9391964 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature